BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9359427)

  • 1. Engineering the substrate specificity of Bacillus megaterium cytochrome P-450 BM3: hydroxylation of alkyl trimethylammonium compounds.
    Oliver CF; Modi S; Primrose WU; Lian LY; Roberts GC
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):537-44. PubMed ID: 9359427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
    Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
    Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
    Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
    Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Thr268 in oxygen activation of cytochrome P450BM-3.
    Yeom H; Sligar SG; Li H; Poulos TL; Fulco AJ
    Biochemistry; 1995 Nov; 34(45):14733-40. PubMed ID: 7578081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam.
    Modi S; Primrose WU; Boyle JM; Gibson CF; Lian LY; Roberts GC
    Biochemistry; 1995 Jul; 34(28):8982-8. PubMed ID: 7619797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of key active-site residues in flavocytochrome P450 BM3.
    Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased substrate affinity upon alteration of the substrate-docking region in cytochrome P450(BM-3).
    Maves SA; Yeom H; McLean MA; Sligar SG
    FEBS Lett; 1997 Sep; 414(2):213-8. PubMed ID: 9315688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
    Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
    Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional saturation mutagenesis as an approach to identification of substrate specificity determinants in cytochrome P450 BM3.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1993 Nov; 21(4):409S. PubMed ID: 8131983
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
    Murataliev MB; Klein M; Fulco A; Feyereisen R
    Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox characterisation of flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S628. PubMed ID: 9450056
    [No Abstract]   [Full Text] [Related]  

  • 17. Directed evolution of the fatty-acid hydroxylase P450 BM-3 into an indole-hydroxylating catalyst.
    Li QS; Schwaneberg U; Fischer P; Schmid RD
    Chemistry; 2000 May; 6(9):1531-6. PubMed ID: 10839169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid signals in Bacillus megaterium are attenuated by cytochrome P-450-mediated hydroxylation.
    English N; Palmer CN; Alworth WL; Kang L; Hughes V; Wolf CR
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):363-8. PubMed ID: 9359402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction.
    Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Nat Struct Biol; 1996 May; 3(5):414-7. PubMed ID: 8612070
    [No Abstract]   [Full Text] [Related]  

  • 20. A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A.
    Schwaneberg U; Schmidt-Dannert C; Schmitt J; Schmid RD
    Anal Biochem; 1999 May; 269(2):359-66. PubMed ID: 10222011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.